IP & Copyright
Eli Lilly Joins Sanofi Onslaught as Amgen's Broad Patent Claims Face SCOTUS Scrutiny
Eli Lilly isn't mincing words: Amgen's patents are toast under §112. With SCOTUS oral arguments looming, the biotech world holds its breath.